NIDCD Clinical Trials in Communication Disorders (R01-Clinical Trial Required)

Funder: National Institutes of Health

Due Date: 1/7/2021

Budget: Negotiable

Opportunity: PA-18-334

The NIDCD is committed to identifying effective interventions for the diagnosis, prevention, or treatment of communication disorders by supporting well­designed and well­executed clinical trials. This funding opportunity announcement (FOA) supports investigator initiated low risk clinical trials addressing the mission and research interests of NIDCD.  Clinical trials must meet ALL the following criteria: meet the budget limits of this FOA, not require FDA oversight, are not intended to formally establish efficacy and have low risks to potentially cause physical or psychological harm.

It is advisable that only one clinical trial be proposed in each NIDCD Clinical Trials in Communication Disorders R01 application.

High risk clinical trials not meeting all the criteria above are referred companion U01 FOA PAR-18-340, NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders.

Leave a Reply